Bristol-Myers Squibb Company (BMY)
NYSE • Healthcare
July 2, 2026 at 20:00 UTC
About Bristol-Myers Squibb Company
Bristol-Myers Squibb Company (NYSE: BMY) develops, manufactures, and sells prescription medicines as a large biopharmaceutical company in healthcare. Across hematology, cancer, cardiovascular, immune, neurological, fibrotic, and infectious-disease treatment areas, it generated $48.2 billion of revenue in FY2025 through a portfolio that spans oncology, immunology, and cardiovascular therapies.
Analyst Ratings
Fundamentals & Financials
TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.
Income Statement
Balance Sheet
Financial Highlights
Dividends History
Split History
Earnings Calendar
Technical Indicators
Bristol-Myers Squibb Company's Technical Indicators Summary
Bristol-Myers Squibb displays a broadly constructive setup with price above most short- and medium-term moving averages and comfortably above the 200-day level, even as the 100-day is nearby. Momentum measures are mildly positive with CCI and a tepid MACD, while RSI sits in neutral territory and ADX indicates only a weak trend. Volatility is contained and ATR is moderate, and on-balance volume readings are mixed but not decisively negative. Technical takeaway: Strong Buy.
| Indicator | Value |
|---|---|
RSI (14) | 56.05 |
Stochastic %K (14, 3, 3) | 72.73 |
CCI (20) | 102.34 |
WPR (14) | -13.79 |
Momentum (10) | 2.85 |
MFI | 48.10 |
MACD Level (12, 26) | 0.11 |
Bollinger Bands | $53.91 - $58.68 |
ATR (14) | $1.46 (2.51%) |
ADX (14) | 14.14 |
OBV | -64,453,674 |
Classic Pivot Point | $56.81 |
Fibonacci Pivot Point | $56.81 |
Simple Moving Averages | $54.02 - $58.37(5 indicators) |
Exponential Moving Averages | $53.67 - $56.93(5 indicators) |
Get premium market insights delivered directly to your inbox.
Today's Snapshot
The day concluded with BMY retaining the 2.94% gap it started with from yesterday. By the close, sector strength was clear, with a 2.65% gain underpinning risk appetite. The day wrapped with modest participation in BMY, as overall volume reached only 0.36× average.
Trading Volume
0
vs S&P 500 Today
Outperforming Market
+1.99%
52-Week Position
Upper range
76.5%
Updated: July 2, 2026 at 20:05 UTC
Quote Summary
BMY Headlines
Fresh Valuation Checks Across Key Stocks
April 4, 2026
Colgate-Palmolive faces key board, dividend moves
March 26, 2026
AI, Capital Moves Shape Key Stock Narratives
March 15, 2026
Markets Swoon as Bitcoin, Tech and Crypto Firms Slide
February 5, 2026